Our Interventional Psychiatry Program specializes in research-backed therapies for patients referred to us by their physicians or psychiatrists. We conduct extensive research, including clinical trials, to discover new ways to treat Treatment Resistant Depression and assess how well existing therapies work.
Electroconvulsive Therapy (ECT)
We are at the forefront of Electroconvulsive therapy. ECT is considered the treatment of choice for patients suffering from severe major depressive disorder who have either not responded to medications or have failed to tolerate medications as a result of various side effects.
Transcranial Magnetic Stimulation (TMS)
We are leaders in treating patients with TRD using transcranial magnetic stimulation (TMS) and vagus nerve stimulation (VNS). Both modalities are in transitional stages and typically not covered by insurance; however, we are able to refer patients to research studies for these treatments.
Esketamine
Esketamine is a prescription nasal spray used to help patients with treatment-resistant depression. Esketamine treatment is rapidly acting and can offer relief to patients who haven’t had success with other antidepressant medications.
Interventional Psychiatrists
John Bilbily
Assistant Professor of Psychiatry
Adult Provider
WashU Direct Provider
- Phone: 314-286-1700
Locations:
- Taylor Avenue Building
Kacie Brooks
Physician Assistant
Adult Provider
WashU Direct Provider
- Phone: 314-286-1700
Locations:
- Taylor Avenue Building
Lucia del Pilar Cristancho Pimiento
Professor of Psychiatry
Adult Provider
WashU Direct Provider
- Phone: 314-286-1700
Locations:
- Taylor Avenue Building
Baris Ercal
Assistant Professor of Psychiatry
Adult Provider
WashU Direct Provider
- Phone: 314-286-1700
Locations:
- Taylor Avenue Building
Angela Lin
Assistant Professor of Psychiatry
Adult Provider
- Phone: 314-286-1700
Locations:
- Taylor Avenue Building